Amedisys Earnings: Here’s Why the Stock is Rising Now

Amedisys Inc. (NASDAQ:AMED) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are up 11.66%.

Amedisys Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 37.04% to $0.17 in the quarter versus EPS of $0.27 in the year-earlier quarter.

Revenue: Decreased 17.28% to $313.1 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Amedisys Inc. reported adjusted EPS income of $0.17 per share. By that measure, the company beat the mean analyst estimate of $0.10. It missed the average revenue estimate of $328.02 million.

Quoting Management: William F. Borne, Chief Executive Officer stated, “We are pleased to report adjusted earnings for the second quarter of $0.17 per share, an improvement of $0.03 sequentially. Despite a $0.09 negative impact from sequestration and continued lower volumes, reductions in operating expenses led to the improved results. We continue to make progress on numerous strategic initiatives focused on growth, increasing efficiency and continued improvement in patient outcomes.”

Key Stats (on next page)…

EPS increased 30.77% from $0.13 in the previous quarter.

Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.14 to a profit $0.13. For the current year, the average estimate has moved down from a profit of $0.51 to a profit of $0.49 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]